Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
HLF
|
John De Simone
Chief Financial Officer |
SELL
Open market or private sale
|
Indirect | 6,180 Reduced 8.47% |
$364,620
$59.0 p/Share
|
Feb 10
2021 |
|
HLF
|
David Pezzullo
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 34,683 Reduced 17.29% |
$1,996,354
$57.56 p/Share
|
Feb 10
2021 |
|
KN
|
Raymond D. Cabrera
SVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct | 6,786 Reduced 8.61% |
$140,674
$20.73 p/Share
|
Feb 10
2021 |
|
ADPT
|
Chad M Robins
CEO and Chairman |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 0.58% |
$629,000
$62.9 p/Share
|
Feb 10
2021 |
|
NX
|
William C Griffiths
Director |
SELL
Open market or private sale
|
Direct | 15,792 Reduced 6.33% |
$386,272
$24.46 p/Share
|
Feb 10
2021 |
|
KNSA
|
Sanj K Patel
CHAIRMAN & CEO |
SELL
Open market or private sale
|
Direct | 1,600 Reduced 100.0% |
$36,896
$23.06 p/Share
|
Feb 10
2021 |
|
KNSA
|
Sanj K Patel
CHAIRMAN & CEO |
SELL
Open market or private sale
|
Indirect | 1,137 Reduced 1.35% |
$26,231
$23.07 p/Share
|
Feb 10
2021 |
|
ICHR
|
Thomas M Rohrs
Director |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 20.07% |
$1,036,500
$41.46 p/Share
|
Feb 10
2021 |
|
IDYA
|
Mark Lackner
SVP, Head of Biology |
SELL
Open market or private sale
|
Direct | 596 Reduced 100.0% |
$12,516
$21.0 p/Share
|
Feb 10
2021 |
|
RMNI
|
Daniel B. Winslow
EVP, CLO & Corp. Sec. |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 34.06% |
$85,700
$8.57 p/Share
|
Feb 10
2021 |
|
RLMD
|
Sergio Traversa
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 1,930 Reduced 2.13% |
$68,090
$35.28 p/Share
|
Feb 10
2021 |
|
RLMD
|
Maged Shenouda
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 2,410 Reduced 51.96% |
$84,832
$35.2 p/Share
|
Feb 10
2021 |
|
ONEW
|
John Troiano |
SELL
Open market or private sale
|
Indirect | 20,000 Reduced 4.91% |
$723,400
$36.17 p/Share
|
Feb 10
2021 |
|
VRM
|
David K. Jones
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 9,895 Reduced 21.2% |
$495,047
$50.03 p/Share
|
Feb 10
2021 |
|
GHL
|
David Wyles
President |
SELL
Open market or private sale
|
Direct | 36,767 Reduced 36.78% |
$552,240
$15.02 p/Share
|
Feb 10
2021 |
|
RDI
|
Margaret Cotter
Chairperson, EVP - RE Dev/NY |
SELL
Open market or private sale
|
Indirect | 4,000 Reduced 0.24% |
$26,080
$6.52 p/Share
|
Feb 10
2021 |
|
RDI
|
James J. Cotter Living Trust
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 0.24% |
$26,080
$6.52 p/Share
|
Feb 10
2021 |
|
RDI
|
Ellen M Cotter
Director, President and CEO |
SELL
Open market or private sale
|
Indirect | 4,000 Reduced 0.24% |
$26,080
$6.52 p/Share
|
Feb 10
2021 |
|
PXLW
|
Todd Debonis
President and CEO |
SELL
Open market or private sale
|
Direct | 34,546 Reduced 3.01% |
$128,166
$3.71 p/Share
|
Feb 10
2021 |
|
LOV
|
Canaan Viii LP
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 0.29% |
$80,200
$8.02 p/Share
|
Feb 10
2021 |
|
RUBY
|
David R Epstein
Director |
SELL
Open market or private sale
|
Direct | 7,404 Reduced 0.16% |
$109,505
$14.79 p/Share
|
Feb 10
2021 |
|
EMAN
|
Stillwater Holdings LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 123,715 Reduced 9.82% |
$473,828
$3.83 p/Share
|
Feb 10
2021 |
|
AAM-PA
|
Joshua Harris
Director |
SELL
Open market or private sale
|
Indirect | 273,588 Reduced 100.0% |
$14,117,140
$51.6 p/Share
|
Feb 10
2021 |
|
ARES
|
Bennett Rosenthal
Co-Founder & Chairman of PEG |
SELL
Open market or private sale
|
Indirect | 83,050 Reduced 10.4% |
$4,218,110
$50.79 p/Share
|
Feb 10
2021 |
|
BILL
|
Rory O'Driscoll
Director |
SELL
Open market or private sale
|
Indirect | 15,000 Reduced 14.75% |
$2,689,350
$179.29 p/Share
|
Feb 10
2021 |
|
LFUS
|
Nathan Zommer
Director |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 1.83% |
$1,354,050
$270.81 p/Share
|
Feb 10
2021 |
|
SPPI
|
Keith M Mc Gahan
Officer |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 1.01% |
$9,825
$3.93 p/Share
|
Feb 10
2021 |
|
AQST
|
Alexander Mark Schobel
Chief Innovation/Tech Officer |
SELL
Open market or private sale
|
Direct | 23,460 Reduced 2.73% |
$158,355
$6.75 p/Share
|
Feb 10
2021 |
|
AMGN
|
Ronald D Sugar
Director |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 5.95% |
$238,400
$238.4 p/Share
|
Feb 10
2021 |
|
META
|
Mark Zuckerberg
COB and CEO |
SELL
Open market or private sale
|
Indirect | 44,750 Reduced 34.86% |
$12,125,460
$270.96 p/Share
|
Feb 10
2021 |
|
PANW
|
Lee Klarich
EVP Chief Product & Tech Ofcr |
SELL
Open market or private sale
|
Direct | 2,539 Reduced 0.84% |
$998,893
$393.42 p/Share
|
Feb 10
2021 |
|
CSL
|
John E Berlin
President, CIT |
SELL
Open market or private sale
|
Direct | 6,506 Reduced 17.65% |
$969,784
$149.06 p/Share
|
Feb 10
2021 |
|
FIBK
|
Jeremy Scott
Director |
SELL
Open market or private sale
|
Indirect | 200 Reduced 0.82% |
$8,714
$43.57 p/Share
|
Feb 10
2021 |
|
EXPI
|
Jason Gesing |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 1.73% |
$2,951,000
$147.55 p/Share
|
Feb 10
2021 |
|
RNST
|
John Creekmore
Director |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 25.08% |
$192,900
$38.58 p/Share
|
Feb 10
2021 |
|
MNRO
|
Peter J Solomon |
SELL
Open market or private sale
|
Direct | 3,604 Reduced 1.09% |
$224,097
$62.18 p/Share
|
Feb 10
2021 |
|
AMK
|
Carrie E. Hansen
EVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 32,160 Reduced 25.58% |
$848,702
$26.39 p/Share
|
Feb 10
2021 |
|
AMK
|
Ted F. Angus
EVP, General Counsel |
SELL
Open market or private sale
|
Direct | 16,687 Reduced 12.24% |
$440,203
$26.38 p/Share
|
Feb 10
2021 |
|
MLAB
|
John Bradley Schmieder
Director |
SELL
Open market or private sale
|
Direct | 1,750 Reduced 2.38% |
$486,903
$278.23 p/Share
|
Feb 10
2021 |
|
BRKL
|
Darryl J. Fess
CEO, Brookline Bank |
SELL
Open market or private sale
|
Direct | 7,500 Reduced 15.71% |
$100,800
$13.44 p/Share
|
Feb 10
2021 |
|
WNC
|
Larry J Magee
Director |
SELL
Open market or private sale
|
Direct | 9,000 Reduced 7.67% |
$152,550
$16.95 p/Share
|
Feb 10
2021 |
|
ACCO
|
Pamela R Schneider
Sr VP, General Counsel & Sec |
SELL
Open market or private sale
|
Direct | 8,602 Reduced 5.48% |
$81,719
$9.5 p/Share
|
Feb 10
2021 |
|
FMNB
|
Brian E Jackson
Sr VP/CIO |
SELL
Open market or private sale
|
Direct | 1,500 Reduced 7.7% |
$21,030
$14.02 p/Share
|
Feb 10
2021 |
|
CLSH
|
Todd V Swanson |
SELL
Open market or private sale
|
Indirect | 20,000 Reduced 0.15% |
$7,600
$0.38 p/Share
|
Feb 10
2021 |
|
MRNA
|
Stephane Bancel
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 9,000 Reduced 0.14% |
$1,644,660
$182.74 p/Share
|
Feb 10
2021 |
|
TPTX
|
Athena Countouriotis
President & CEO |
SELL
Open market or private sale
|
Direct | 25,392 Reduced 33.59% |
$3,464,230
$136.43 p/Share
|
Feb 10
2021 |
|
MA
|
Foundation Mastercard |
SELL
Open market or private sale
|
Direct | 57,198 Reduced 0.05% |
$19,085,257
$333.67 p/Share
|
Feb 10
2021 |
|
AVGO
|
Eddy W Hartenstein
Director |
SELL
Open market or private sale
|
Direct | 530 Reduced 5.88% |
$250,229
$472.13 p/Share
|
Feb 10
2021 |
|
GTE
|
Gmt Capital Corp
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 2,186,900 Reduced 4.09% |
$2,077,555
$0.95 p/Share
|
Feb 10
2021 |
|
MDLZ
|
May Peter W
Director |
SELL
Open market or private sale
|
Indirect | 180,998 Reduced 1.61% |
$10,077,969
$55.68 p/Share
|
Feb 10
2021 |